AVEYABEK
DEAD

Serial Number

88879904

Owner

Celgene Corporation

Attorney

Marilyn F. Kelly

Filing Date

Apr 20, 2020

Add to watchlist:

No watchlists yet
View on USPTO

AVEYABEK Trademark

Serial Number: 88879904

AVEYABEK is a trademark filed by Celgene Corporation on April 20, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Celgene Corporation (883 trademarks)

7 Powder Horn Drive
Warren, NJ 07059

Entity Type: 03

Trademark Details

Filing Date

April 20, 2020

Registration Date

Not Registered

Published for Opposition

June 1, 2021

Goods & Services

Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Sep 2, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 2, 2024 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 23, 2024 EXRA
SOU EXTENSION 5 GRANTED
Jan 22, 2024 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 22, 2024 AITU
SOU EXTENSION 5 FILED
Jan 3, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
Jan 3, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 15, 2023 EXRA
SOU EXTENSION 4 GRANTED
Jul 13, 2023 EX4G
SOU EXTENSION 4 FILED
Jul 13, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 13, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 26, 2023 EXRA
SOU EXTENSION 3 GRANTED
Jan 24, 2023 EX3G
SOU EXTENSION 3 FILED
Jan 24, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 24, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 15, 2022 EXRA
SOU EXTENSION 2 GRANTED
Jul 13, 2022 EX2G
SOU EXTENSION 2 FILED
Jul 13, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 13, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 21, 2022 EXRA
SOU EXTENSION 1 GRANTED
Jan 19, 2022 EX1G
SOU EXTENSION 1 FILED
Jan 19, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 19, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 27, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 1, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jun 1, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 12, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 27, 2021 CNSA
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 26, 2021 GNFN
FINAL REFUSAL E-MAILED
Jan 26, 2021 GNFR
FINAL REFUSAL WRITTEN
Jan 26, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 12, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 11, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 11, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 14, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jul 14, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jul 14, 2020 CNRT
ASSIGNED TO EXAMINER
Jul 11, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 29, 2020 NWOS
NEW APPLICATION ENTERED
Apr 23, 2020 NWAP